New Delhi, Nov. 20 -- Feluda, the indigenously developed testing kit for coronavirus disease (Covid-19) based on the gene-editing technology Crispr will be rolled out across eight centres of Apollo hospitals in eight metro cities, beginning with Delhi, people familiar with the matter said. The kit was launched by the Tata group in collaboration with the Apollo group of hospitals on Thursday....